Compare AdaptHealth Corp (AHCO) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs State Street SPDR S&P Biotech ETF — how do they compare? AdaptHealth Corp trades at $5.72 (market cap $771.10M), while State Street SPDR S&P Biotech ETF trades at $157.14. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | XBI | |
|---|---|---|
Market Cap | $771.10M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $13.38 | $164.28 |
52-Week Low | $5.22 | $88.79 |
Enterprise Value | $2.79B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
